Arteriogenesis induced by intramyocardial vascular endothelial growth factor 165 gene transfer in chronically ischemic pigs

Human Gene Therapy

Volumn 14, Issue 14, 2003, Pages 1307-1318

  Crottogini, Alberto ^a   Martínez, Verónica ^a   De Lorenzi, Andrea ^b   Telayna, Juan ^b   Mele, Aníbal ^b   Fernández, José L ^d   Marangunich, Laura ^d   Criscuolo, Marcelo ^d   Capogrossi, Maurizio C ^e   Laguens, Rubén ^a,b   Meckert, Patricia Cabeza ^b,c   Vera Janavel, Gustavo ^a   Lascano, Elena ^a   Negroni, Jorge ^a   Del Valle, Héctor ^a   Dulbecco, Eduardo ^b   Werba, Pablo ^a,b   Cuniberti, Luis ^a  

^a FAVALORO UNIVERSITY   (Argentina)

^b HOSPITAL UNIVERSITARIO FUNDACIÓN FAVALORO   (Argentina)

^c Scientific Research Commission   (Argentina)

^d Bio Sidus   (Argentina)

^e LABORATORIO DI PATOLOGIA VASCOLARE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

DOBUTAMINE; PLACEBO;

ANGIOGENESIS; ARTICLE; CELL PROLIFERATION; COLLATERAL CIRCULATION; CONTROLLED STUDY; CORONARY ARTERY CIRCUMFLEX BRANCH; CORONARY ARTERY DISEASE; DATA ANALYSIS; DENSITY; DISEASE SEVERITY; GENE TRANSFER; HEART FUNCTION; HEART MUSCLE ISCHEMIA; HUMAN; MAMMAL; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SMOOTH MUSCLE; SWINE; TISSUE PERFUSION;

ANIMALS; CARDIOTONIC AGENTS; COLLATERAL CIRCULATION; CORONARY ANGIOGRAPHY; CORONARY VESSELS; DISEASE MODELS, ANIMAL; DOBUTAMINE; ECHOCARDIOGRAPHY; GENE EXPRESSION; GENE TRANSFER TECHNIQUES; IMMUNOHISTOCHEMISTRY; MYOCARDIAL ISCHEMIA; NEOVASCULARIZATION, PHYSIOLOGIC; STRESS; SWINE; TECHNETIUM TC 99M SESTAMIBI; TIME FACTORS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TRANSGENES; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

AMEROIDEA; ANIMALIA; MAMMALIA; SUS SCROFA;

EID: 10744230276     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/104303403322319390     Document Type: Article

References (41)

1. ADAIR, T.H., WELLS, M.L., HANG, J., and MONTANI, J.P. (1994). A stereological method for estimating length density of the arterial vascular system. Am. J. Physiol. 266, H1434-H1438.
2. ANVERSA, P., and CAPASSO, J.M. (1991). Loss of intermediate-size coronary arteries and capillary proliferation following left ventricular failure in rats. Am. J. Physiol. 260, H1552-H1560.
3. BANAI, S., JAKLITSCH, M.T., SHOU, M., LAZAROUS, D.F., SCHEINOWITZ, M., BIRO, S., EPSTEIN, S.E., and UNGER, E.F. (1994). Angiogenic-induced enhancement of collateral blood flow to ischemic myocardium by vascular endothelial growth factor in dogs. Circulation 89, 2183-2189.
4. BENJAMIN, L.E., HEMO, I., and KESHET, E. (1998). A plasticity window for blood vessel remodelling is defined by pericyte coverage of the preformed endothelial network and is regulated by PDGF-B and VEGF. Development 125, 1591-1598.
5. CARMELIET, P. (2000). Mechanisms of angiogenesis and arteriogenesis. Nat. Med. 6, 389-395.
6. CARMELIET, P., NG, Y-S., NUYENS, D., THEILMEIER, G., BRUSSELMANS, K., CORNELISSEN, I., EHLER, E., KAKKAR, V., STALMANS, I., MATTOT, V., PERRIARD, J-C., DEWERCHIN, M., FLAMENG, W., NAGY, A., LUPU, F., MOONS, L., COLLEN, D., D'AMORE, P.A., and SHIMA, D. (1999). Impaired myocardial angiogenesis and ischemic cardiomyopathy in mice lacking the vascular endothelial growth factor isoforms VEGF164 and VEGF188. Nat. Med. 5, 495-502.
7. CHIU, R. C.-J. (2001). Therapeutic cardiac angiogenesis and miogenesis: the promises and challenges on a new frontier. J. Thorac. Cardiovasc. Surg. 122, 851-852.
8. COUFFINHAL, T., SILVER, M., ZHENG, L., KEARNEY, M., WITZENBICHLEN, B., and ISNER, J. (1998). Mouse model of angiogenesis. Am. J. Pathol. 152, 1667-1679.
9. FERRARA, N., GERBER, H.-P., and LECOUTER, J. (2003). The biology of VEGF and its receptors. Nat. Med. 9, 669-676.
10. 121 gene transfer stimulates angiogenesis in normoperfused skeletal muscle and preserves tissue perfusion after induction of ischemia. Circulation 102, 565-571.
11. GROSSKREUTZ, C.L., ANAND-APTE, B., DUPLÁA, C., QUINN, T.P., TERMAN, B.I., ZETTER, B., and D'AMORE, P.A. (1999). Vascular endothelial growth factor-induced migration of vascular smooth muscle cells in vitro. Microvasc. Res. 58, 128-136.
12. HACHAMOVITCH, R., BERMAN, D., KIAT, H., COHEN, I., CABICO, A., FRIEDMAN, J., DIAMOND, G. (1996). Exercise myocardial perfusion SPECT in patients without known coronary artery disease. Circulation 93, 905-914.
13. HARADA, K., FRIEDMAN, M., LOPEZ, J.J., WANG, S.Y., LI, J., PRASAD, P.V., PEARLMAN, J.D. EDELMAN, E.R., SELLKE, F.W., and SYMONS, M. (1996). Vascular endothelial growth factor administration in chronic myocardial ischemia. Am. J. Physiol. 270, H1791-H1802.
14. HARIAWALA, M.D., HOROWITZ, J.R., ESAKOF, D., SHERIFF, D.D., WALTER, D.H., KEYT, B., ISNER, J.M., and SYMES, J.F. (1996). VEGF improves myocardial blood flow but produces EDRF-mediated hypotension in porcine hearts. J. Surg. Res. 63, 77-82.
15. HENDEL, R.C., HENRY, T.D., ROCHA-SINGH, K., ISNER, J.M., KEREIAKES, D.J., GIORDANO, F.J., SIMONS, M., and BONOW, R.O. (2000). Effect of intracoronary recombinant human vascular endothelial growth factor on myocardial perfusion: Evidence for a dose-dependent effect. Circulation 101, 118-121.
16. HENRY, T.D., ROCHA-SINGH, K., ISNER, J.M., KEREIAKES, D.J., GIORDANO, F.J., SIMONS, M., LOSORDO, D.W., HENDEL, R.C., BONOW, R.O., EPPLER, S.M., ZIONCHECK, T.F., HOLMGREN, E.B., and MCCLUSKEY, E.R. (2001). Intracoronary administration of recombinant human vascular endothelial growth factor to patients with coronary artery disease. Am. Heart J. 142, 872-880.
17. ISHIDA, A., MURRAY, J., SAITO, Y., KANTHOU, C., BENZAKOUR, O., SHIBUYA, M., and WIJELATH, E.S. (2001). Expression of vascular endothelial growth factor receptors in smooth muscle cells. J. Cell. Physiol. 188, 359-368.
18. 165 gene transfer. Gene Ther. 9, 1676-1681.
19. LOPEZ, J.J., EDELMAN, E.R., STAMLER, A., HIBBERD, M.G., POTTUMARTHI, P., THOMAS, K.A., DISALVO, J., CAPUTO, R.P., CARROZZA, J.P., DOUGLAS, P.S., SELLKE, F.W., and SIMONS, M. (1998a). Angiogenic potential of perivascularly delivered aFGF in a porcine model of chronic myocardial ischemia. Am. J. Physiol. 274, H930-H936.
20. LOPEZ, J.J., LAHAM, R.J., STAMLER, A., PEARLMAN, I.D., BUNTING, S., KAPLAN, A., CARROZZA, J.P., SELLKE, F.W., and SIMONS, M. (1998b). VEGF administration in chronic myocardial ischemia in pigs. Cardiovasc. Res. 40, 272-281.
21. LOSORDO, D.W., VALE, P.R., HENDEL, R.C., MILLIKEN, C.E., FORTUIN, F.D., CUMMINGS, N., SCHATZ, R.A., ASAHARA, T., ISNER, J.M., and KUNTZ, R.E. (2002). Phase 1/2 placebo-controlled, double-blind, dose-escalating trial of myocardial vascular endothelial growth factor 2 gene transfer by catheter delivery in patients with chronic myocardial ischemia. Circulation 105, 2012-2018.
22. MACK, C.A., PATEL, S.R., SCHWARZ, E.A., ZANZONICO, P., HAHN, R.T., ILERCIL, A., DEVEREUX, R.V., GOLDSMITH, S.J., CHRISTIAN, T.F., SANBORN, T.A., VOVESDI, I., HACKETT, N., ISOM, O.W., CRYSTAL, R.G., and ROSENGART, T.K. (1998). Biologic bypass with the use of adenovirus-mediated gene transfer of the complementary deoxiribonucleic acid for vascular endothelial growth factor 121 improves myocardial perfusion and function in the ischemic porcine heart. J. Thorac. Cardiovasc. Surg. 115, 168-177.
23. PATEL, S.R., LEE, L.Y., MACK, C.A., POLCE, D.R., EL-SAWY, T., HACKETT, N.R., ILERCIL, A., JONES, E.C., HAHN, R.T., ISOM, O.W., ROSENGART, T.K., and CRYSTAL, R.G. (1999). Safety of direct myocardial administration of an adenovirus vector encoding vascular endothelial growth factor 121. Human Gene Ther. 10, 1331-1348.
24. PEARLMAN, I.D., HIBBERD, M.G., CHUANG, M.L., HARADA, K., LOPEZ, J.J., GLADSTONE, S.R., FRIEDMAN, M., SELLKE, F.W., and SIMONS, M. (1995). Magnetic resonance mapping demonstrates benefits of VEGF-induced myocardial angiogenesis. Nat. Med. 1, 1085-1089.
25. PETTERSSON, A., NAGY, J.A., BROWN, L.F., SUNDBERG, C., MORGAN, E., JUNGLES, S., CARTER, R., KRIEGER, J.E., MANSEAU, E.J., HARVEY, V.S., ECKELHOEFER, I.A., FENG, D., DVORAK, A.M., MULLIGAN, R.C., and DVORAK, H.F. (2000). Heterogeneity of the angiogenic response induced in different normal adult tissues by vascular permeability factor/vascular endothelial growth factor. Lab. Invest. 80, 99-115.
26. RENTROP, K.P., COHEN, M., BLANKE, H., and PHILLIPS, R.A. (1985). Changes in collateral channel filling immediately after controlled coronary artery occlusion by an angioplasty balloon in human subjects. J. Am. Coll. Cardiol. 5, 587-592.
27. 165 gene transfer enhances wound healing by promoting angiogenesis in CD1 diabetic mice. Gene Ther. 9, 1271-1277.
28. 121 cDNA to individuals with clinically significant severe coronary artery disease. Circulation 100, 468-474.
29. SATO, K., WU, T., LAHAM, R.J., JOHNSON, R.G., DOUGLAS, P., LI, J., SELLKE, F.W., BUNTING, S., SIMONS, M., and POST, M.J. (2001). Efficacy of intracoronary or intravenous VEGF165 in a pig model of chronic myocardial ischemia. J. Am. Coll. Cardiol. 37, 616-623.
30. SAYEED-SHAH, U., MANN, M.J., MARTIN, J., GRACHEV, S., REIMOLD, S., LAURENCE, R., DZAU, V., and COHN, L.H. (1998). Complete reversal of ischemic wall motion abnormalities by combined use of gene therapy with transmyocardial laser revascularization. J. Thorac. Cardiovasc. Surg. 116, 763-769.
31. SCHAPER, W. (2000). Quo vadis collateral blood flow?: A commentary on a highly cited paper. Cardiovasc. Res. 45, 220-223.
32. SCHAPER W. (2001). Therapeutic angiogenesis has arrived. Circulation 104, 1994-1995.
33. SCHILLER, N.B., SHAH, P.M., CRAWFORD, M., DEMARIA, A., DEVEREUX, R., FEIGENBAUM, H., GUTGESELL, H., REICHEK, N., SAHN, D., SCHNITTGER, I., SILVERMAN, N.H., and TAJIK, A.J. (1989). Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J. Am. Soc. Echocardiogr. 2, 358-367.
34. SCHWARZ, E.R., SPEAKMAN, M.T., PATTERSON, M., HALE, S.S., ISNER, J.M., KEDES, L.H., and KLONER, R.A. (2000). Evaluation of the effects of intramyocardial injection of DNA expressing vascular endothelial growth factor (VEGF) in a myocardial infarction model in the rat: Angiogenesis and angioma formation. J. Am. Coll. Cardiol. 35, 1323-1330.
35. SEILER, C., POHL, T., WUSTMANN, K., HUTTER, D., NICOLET, P-A., WINDECKER, S., EBERLI, F.R., and MEIER, B. (2001). Promotion of collateral growth by granulocyte-macrophage colony-stimulating factor in patients with coronary artery disease. A randomized, double-blind, placebo-controlled study. Circulation 104, 2012-2017.
36. SU, H., LU, R., and KAN, Y.W. (2000). Adeno-associated viral vector-mediated vascular endothelial growth factor gene transfer induces neovascular formation in ischemic heart. Proc. Natl. Acad. Sci. U.S.A. 97, 13801-13806.
37. SYMES, J.F., LOSORDO, D.W., VALE, P.R., LATHI, K.G., ESAKOF, D.D., MAYSKY, M., and ISNER, J.M. (1999). Gene therapy with vascular endothelial growth factor for inoperable coronary artery disease. Ann. Thorac. Surg. 68, 830-837.
38. TIO, R.A., TKEBUCHAVA, T., SCHEUERMANN, T.H., LEBHERZ, C., MAGNER, M., KEARNY, M., ESAKOF, D.D., ISNER, J.M., and SYMES, J.F. (1999). Intramyocardial gene therapy with naked DNA encoding vascular endothelial growth factor improves collateral flow to ischemic myocardium. Hum. Gene Ther. 10, 2953-2960.
39. TOMANEK, R.J., ZIMMERMAN, M.B., SUVARNA, P.R., MORKIN, E., PENNOCK, G.D., and GOLDMAN, S. (1998). A thyroid hormon analog stimulates angiogenesis in the post-infarcted rat heart. J. Mol. Cell. Cardiol. 30, 923-932.
40. TOMANEK, R.J., SANDRA, A., ZHENG, W., BROCK, T., BJERCKE, R.J., and HOLIFIELD, J.S. (2001). Vascular endothelial growth factor and basic fibroblast growth factor differentially modulate early postnatal coronary angiogenesis. Circ. Res. 88, 1135-1141.
41. YOKOYAMA, M., and HIRASE, T. (2001). Harmonic interplay of angiogenic growth factors in the development of coronary blood vessels. Circ. Res. 88, 1099-1101.